News

The Protein Folding and Conformational Diseases research group, led by Salvador Ventura, defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a review study published in the journal Trends in Pharmacological Sciences.

Research Group: Nanobiotechnology

A recent study presents a method for detecting Alzheimer's disease before neuronal damage becomes extensive. The study used small plasma particles called exosomes, obtained through liquid biopsy, because they carry molecular information from their cells of origin. Despite the difficulty involved, preliminary studies are very promising in terms of the ability to capture brain-derived exosomes. This could make it feasible to detect the disease at very early stages and move towards a tool to support screening and monitoring, which is the objective of the research.

IBB-UAB researcher Aura Muntasell has been selected one of the eight finalists for the fifteenth edition of the Vanguardia de la Ciència Award, a recognition that highlights the most outstanding contributions of research led by institutions in Spain. Her candidacy stands out for the development of an innovative immunotherapy strategy against cancer, with the potential to improve the effectiveness of current treatments. Voting to choose the winning research is open to the public until 28 June.

The visit takes place within the framework of the ECIU Seed project “BEAT”, in which the researcher Òscar Quijada participates as a partner

Ranking from “Research.com” 2026

How IBB is Connecting with Catalonia’s Microvillages

Research group: Bacterial Blood Pathogens

Research group: Bacterial Blood Pathogens

Research groups: Biosensing and Bioanalysis, Cellular Immunology